mesowatch
HomeBankruptcy Judge Approves J&J’s ‘Stooge’ Talc Subsidiary in Legal Maneuver
divider

Bankruptcy Judge Approves J&J’s ‘Stooge’ Talc Subsidiary in Legal Maneuver

talc case bankruptcy judge

In a contentious legal battle, U.S. Bankruptcy Judge Michael B. Kaplan recently refused to dismiss the Chapter 11 case of LTL Management, a subsidiary of Johnson & Johnson. This decision, which allows J&J to navigate its mass tort liability, has ignited a firestorm of criticism from talc injury attorneys and advocates. They argue that J&J’s strategic use of bankruptcy deprives claimants of their right to a fair trial.

The Texas Two-Step Tactic Under Scrutiny

At the heart of the controversy lies what many term the “Texas two-step strategy.” This maneuver involves a solvent company executing a divisive merger, emerging as two separate entities. J&J’s application of this tactic, deemed valid by Judge Kaplan, has spurred calls for legislative intervention.

Prominent figures in the legal realm have condemned J&J’s actions. Senator Dick Durbin of Illinois has vowed to draft legislation to outlaw what he describes as a “shameful scheme” by the corporate giant. Michelle Parfitt of Ashcraft & Gerel echoes these sentiments, emphasizing the urgent need for Congress to safeguard consumers’ rights.

Jon Ruckdeschel, a veteran in asbestos-related litigation, expressed disappointment over the ruling, stressing the necessity of legislative measures to prevent similar abuses. Meanwhile, J&J and LTL defend their stance, asserting that bankruptcy offers the most practical solution to handle existing and future claims.

Despite the setback, talc claimants committees remain resolute in their fight for justice. While an appeal is on the horizon, attention turns to Capitol Hill, where lawmakers grapple with the prospect of enacting significant bankruptcy reform.

As legislative efforts gain momentum, experts predict a turbulent path. Ted Gavin, a turnaround specialist, acknowledges the uphill battle, citing the political climate as a significant obstacle. Nevertheless, the spotlight on J&J’s controversial tactics may catalyze long-overdue reforms.

With tensions escalating and battle lines drawn, the clash between J&J and its detractors underscores the high stakes in the realm of mass tort litigation. As the legal saga unfolds, all eyes remain fixed on the halls of Congress, where the fate of bankruptcy reform hangs in the balance.

Johnathan Edwards

Reading Time: 1 mins

Published On: March 4, 2022

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer